PEEKPilotZyg: PEEK Prostheses in the All-on-4 Concept Using Zygomatic Implants for Full-arch Rehabilitation.

Sponsor
Malo Clinic (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05589545
Collaborator
Invibio Ltd (Industry)
10
1
1
54.5
0.2

Study Details

Study Description

Brief Summary

The goal of this study is to evaluate the outcome of a Poly-ether-ether-ketone - acrylic resin prosthesis for full-arch rehabilitation of the atrophic maxillae through the All-on-4 Hybrid concept (standard and zygomatic implants) after one year of follow-up. The main question it aims to answer is:

  • What is the survival outcome of the full-arch implant-supported Poly-ether-ether-ketone - acrylic resin prosthesis? The participants already rehabilitated with dental implants will receive a Poly-ether-ehter-ketone prosthesis as a definitive prosthesis.
Condition or Disease Intervention/Treatment Phase
  • Device: Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis
N/A

Detailed Description

Following the previous study on the full-arch rehabilitation of edentulous jaws using hybrid prostheses with polyetheretherketone (PEEK) infrastructure and acrylic resin teeth supported by implants in immediate function inserted through the All-on-4 concept it is necessary to further extend the evaluation to the full-arch rehabilitation of severily atrophic maxillae through the use of the same hybrid prostheses supported by immediate function zygomatic implants inserted alone or in combination with conventional implants. To test this, the study design to be used will be a single-centre, prospective, observational cohort study to evaluate the short term outcome of fixed prosthetic implant-supported rehabilitations. The sample of this study consists in 10 patients consecutively treated. The cohort will be evaluated after 4 to 8 weeks, 6 months, 12 months after connection of the prostheses and annually thereafter as long as the patient is willing, regarding: prosthetic survival, implant survival, marginal bone resorption, incidence of mechanical complications (loosening or fracture of prosthetic components), biological complications (peri-implant infection, suppuration, fistulae, sinus infection, gingival dehiscence), patient tissue reaction, aesthetic examination including staining, color stability and anatomic form; patient assessment of in mouth comfort, overall chewing ability, aesthetics and patient quality of life using the Oral Health Impact Profile OHIP-14 questionnaire; assessment of prosthetic preparation (technician satisfaction) concerning laboratory preparation time, clinical operative time and costs.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective cohort studyProspective cohort study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Full-arch Rehabilitation of Severely Atrophic Maxillae Through the Use of Polyetheretherketone (PEEK) Prostheses Supported by Zygomatic Implants in Combination With Conventional Implants Through the All-on-4 Concept.
Actual Study Start Date :
Jul 19, 2019
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis

Device: Prosthetic full-arch rehabilitation using a PEEK-acrylic resin prosthesis
A prosthetic full-arch rehabilitation of atrophic maxillae using a PEEk-acrylic resin prosthesis supported by an ensemble of standard dental implants and zygomatic dental implants, following the All-on-4 Hybrid Concept.
Other Names:
  • PEEK prosthesis
  • Outcome Measures

    Primary Outcome Measures

    1. Survival of the prosthesis [one year]

      Evaluation of the survival for the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

    Secondary Outcome Measures

    1. Survival of the implants [one year]

      Evaluation of the survival for implants supporting the PEEK-acrylic resin implant-supported prosthesis; nominal (survival,failure)

    2. Incidence of biological complications [one year]

      Peri-implant infection, abscess, fistulae, suppuration, sinus infection, gingival dehiscence; Nominal (no incidence, incidence)

    3. Incidence of mechanical complications [one year]

      Loosening or fracture of prosthetic components; Nominal (no incidence, incidence)

    4. Marginal bone resorption (standard implants) [one year]

      Measured through periapical radiographs, in mm between the implant shoulder and the most apical portion of implant-bone contact; Scale

    5. Patient tissue reaction [one year]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    6. Denture staining [one year]

      Veneer staining; 0:heavily stained; 10: no stains

    7. Color stability [one year]

      Color stability; 0: heavy discoloration; 10: no discoloration

    8. Anatomic form [one year]

      Anatomic form; 0: Complete loss of anatomic form; 10: maintained anatomic form

    9. ln mouth comfort [one year]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    10. Aesthetics [one year]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    11. Overall Chewing ability [one year]

      Visual analogue scale (0-10 cm); 0:very poor; 10: very good

    12. Oral Health Impact Profile [One year]

      Oral Health Impact Profile OHIP-14 questionnaire

    13. Laboratory preparation time [one year]

      Average laboratory time to produce the finished prosthesis, the active technician time spent in CAD design, Cam mill and veneering.

    14. Clinical operative time [one year]

      Average operative time to load the final prosthesis

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the clinic for all the required post-operative follow-ups.

    • Subjects who are able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained.

    Exclusion Criteria:
    • Female Subjects who are pregnant.

    • Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-ups or treatment outcomes.

    • Subjects with any condition that would compromise their participation and follow-up in this clinical study.

    • Subjects who are currently enrolled in a clinical study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Malo Clinic Lisbon Portugal 1600-042

    Sponsors and Collaborators

    • Malo Clinic
    • Invibio Ltd

    Investigators

    • Principal Investigator: Miguel A de Araújo Nobre, PhD, Director of Research, Development and Education

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Malo Clinic
    ClinicalTrials.gov Identifier:
    NCT05589545
    Other Study ID Numbers:
    • PEEKPilotZyg
    First Posted:
    Oct 21, 2022
    Last Update Posted:
    Oct 24, 2022
    Last Verified:
    Oct 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Malo Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 24, 2022